ALIGN TECHNOLOGY, INC. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
ALIGN TECHNOLOGY, INC. (ALGN) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $26.59 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-08-05
- ALIGN TECHNOLOGY, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-06-30 was $14.88M, a 105.72% increase year-over-year.
- ALIGN TECHNOLOGY, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-03-31 was $11.71M, a 133.00% increase year-over-year.
- ALIGN TECHNOLOGY, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-12-31 was $2.29M, a 68.34% decline year-over-year.
- ALIGN TECHNOLOGY, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-09-30 was $7.74M, a 197.35% increase year-over-year.
- ALIGN TECHNOLOGY, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2025 was $22.29M, a 31.77% decline from fiscal 2024.
- ALIGN TECHNOLOGY, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $32.67M, a 17.10% increase from fiscal 2023.
- ALIGN TECHNOLOGY, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $27.90M, a 18.28% decline from fiscal 2022.
- ALIGN TECHNOLOGY, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $34.14M, a 50.13% decline from fiscal 2021.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | $14.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $26.59M 10-Q · filed 2026-08-05 | $28.89M derived: sum of 3 quarters · filed 2026-08-05 | $36.62M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $11.71M 10-Q · filed 2026-05-06 | $14.00M derived: sum of 2 quarters · filed 2026-05-06 | $21.74M derived: sum of 3 quarters · filed 2026-05-06 | $28.97M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $2.29M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $10.03M derived: sum of 2 quarters · filed 2026-02-27 | $17.27M derived: sum of 3 quarters · filed 2026-08-05 | $22.29M 10-K · filed 2026-02-27 |
| 2025-09-30 | $7.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $14.97M derived: sum of 2 quarters · filed 2026-08-05 | $20.00M 10-Q · filed 2025-11-05 | $27.25M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $7.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $12.26M 10-Q · filed 2026-08-05 | $19.51M derived: sum of 3 quarters · filed 2026-08-05 | $22.11M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $5.02M 10-Q · filed 2026-05-06 | $12.27M derived: sum of 2 quarters · filed 2026-05-06 | $14.88M derived: sum of 3 quarters · filed 2026-05-06 | $27.13M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $7.25M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $9.85M derived: sum of 2 quarters · filed 2026-02-27 | $22.10M derived: sum of 3 quarters · filed 2026-02-27 | $32.67M 10-K · filed 2026-02-27 |
| 2024-09-30 | $2.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $14.85M derived: sum of 2 quarters · filed 2025-11-05 | $25.42M 10-Q · filed 2025-11-05 | $28.27M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $12.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $22.82M 10-Q · filed 2025-08-06 | $25.67M derived: sum of 3 quarters · filed 2026-02-27 | $29.38M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $10.57M 10-Q · filed 2025-05-08 | $13.42M derived: sum of 2 quarters · filed 2026-02-27 | $17.12M derived: sum of 3 quarters · filed 2026-02-27 | $32.91M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $2.85M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $6.55M derived: sum of 2 quarters · filed 2026-02-27 | $22.34M derived: sum of 3 quarters · filed 2026-02-27 | $27.90M 10-K · filed 2026-02-27 |
| 2023-09-30 | $3.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $19.49M derived: sum of 2 quarters · filed 2024-11-05 | $25.05M 10-Q · filed 2024-11-05 | $32.66M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $15.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $21.35M 10-Q · filed 2024-08-02 | $28.96M derived: sum of 3 quarters · filed 2025-02-28 | $39.14M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $5.56M 10-Q · filed 2024-05-03 | $13.17M derived: sum of 2 quarters · filed 2025-02-28 | $23.35M derived: sum of 3 quarters · filed 2025-02-28 | $27.44M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $7.61M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $17.79M derived: sum of 2 quarters · filed 2025-02-28 | $21.88M derived: sum of 3 quarters · filed 2025-02-28 | $34.14M 10-K · filed 2025-02-28 |
| 2022-09-30 | $10.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $14.27M derived: sum of 2 quarters · filed 2023-11-03 | $26.53M 10-Q · filed 2023-11-03 | $63.36M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $4.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $16.35M 10-Q · filed 2023-08-04 | $53.18M derived: sum of 3 quarters · filed 2024-02-28 | $60.48M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $12.26M 10-Q · filed 2023-05-05 | $49.09M derived: sum of 2 quarters · filed 2024-02-28 | $56.39M derived: sum of 3 quarters · filed 2024-02-28 | $73.36M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $36.83M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $44.13M derived: sum of 2 quarters · filed 2024-02-28 | $61.09M derived: sum of 3 quarters · filed 2024-02-28 | $68.46M 10-K · filed 2024-02-28 |
| 2021-09-30 | $7.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $24.27M derived: sum of 2 quarters · filed 2022-11-04 | $31.64M 10-Q · filed 2022-11-04 | $34.70M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | $16.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $24.34M 10-Q · filed 2022-08-04 | $27.40M derived: sum of 3 quarters · filed 2023-02-27 | $46.77M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | $7.37M 10-Q · filed 2022-05-05 | $10.44M derived: sum of 2 quarters · filed 2023-02-27 | $29.80M derived: sum of 3 quarters · filed 2023-02-27 | $33.75M derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | $3.07M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $22.44M derived: sum of 2 quarters · filed 2023-02-27 | $26.38M derived: sum of 3 quarters · filed 2023-02-27 | $47.98M 10-K · filed 2023-02-27 |
| 2020-09-30 | $19.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $23.31M derived: sum of 2 quarters · filed 2021-11-02 | $44.91M 10-Q · filed 2021-11-02 | $51.24M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-06-30 | $3.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $25.55M 10-Q · filed 2021-08-04 | $31.87M derived: sum of 3 quarters · filed 2022-02-25 | $37.20M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-03-31 | $21.60M 10-Q · filed 2021-05-05 | $27.93M derived: sum of 2 quarters · filed 2022-02-25 | $33.26M derived: sum of 3 quarters · filed 2022-02-25 | $38.34M derived: sum of 4 quarters · filed 2022-02-25 |
| 2019-12-31 | $6.33M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $11.66M derived: sum of 2 quarters · filed 2022-02-25 | $16.74M derived: sum of 3 quarters · filed 2022-02-25 | $32.72M 10-K · filed 2022-02-25 |
| 2019-09-30 | $5.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-30 | $10.41M derived: sum of 2 quarters · filed 2020-10-30 | $26.39M 10-Q · filed 2020-10-30 | |
| 2019-06-30 | $5.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $21.07M 10-Q · filed 2020-07-31 | ||
| 2019-03-31 | $15.98M 10-Q · filed 2020-05-05 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-02-26 | |||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |